MoneyWorks4Me

FDC - Quaterly Results

07 Aug 2024 Evaluate
A fair growth of 17.75% in the revenue at Rs. 6241.41 millions was reported in the June 2024 quarter as compared to Rs. 5300.40 millions during year-ago period.Modest increase of 5.93% in the Net Profit was reported from. 1085.51 millions to Rs. 1149.89  millions.OP of the company witnessed a marginal growth to 1698.46 millions from 1497.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 6241.41 5300.40 17.75 6241.41 5300.40 17.75 19161.87 17770.32 7.83
Other Income 281.53 297.84 -5.48 281.53 297.84 -5.48 1032.16 539.12 91.45
PBIDT 1698.46 1497.90 13.39 1698.46 1497.90 13.39 4416.74 3084.87 43.17
Interest 12.92 10.38 24.47 12.92 10.38 24.47 40.00 40.39 -0.97
PBDT 1685.54 1487.52 13.31 1685.54 1487.52 13.31 4376.74 3044.48 43.76
Depreciation 109.95 95.88 14.67 109.95 95.88 14.67 397.29 387.58 2.51
PBT 1575.59 1391.64 13.22 1575.59 1391.64 13.22 3979.45 2656.90 49.78
TAX 425.70 306.13 39.06 425.70 306.13 39.06 907.82 647.25 40.26
Deferred Tax 65.70 1.13 5714.16 65.70 1.13 5714.16 51.63 -42.75 -220.77
PAT 1149.89 1085.51 5.93 1149.89 1085.51 5.93 3071.63 2009.65 52.84
Equity 162.81 165.91 -1.87 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 27.21 28.26 -3.71 27.21 28.26 -3.71 23.05 17.36 32.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..